5 completed, 2 active not recruiting. 4 Phase 1, 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 3 | Active not recruiting 2, Completed 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Belite Bio, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease Tinlarebant, Placebo - STGD1, Stargardt Disease 1 | Phase 2 / Phase 3 | Active not recruiting | Belite Bio, Inc | 60 | 2024-07-31 | 2026-03-12 |
| Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy Tinlarebant, Placebo - Geographic Atrophy | Phase 3 | Active not recruiting | Belite Bio, Inc | 429 | 2023-07-27 | 2026-01-07 |
| Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85 Tinlarebant (LBS-008) - Healthy Volunteer, Dry Age-related Macular Degeneration | Phase 1 | Completed | RBP4 Pty Ltd | 15 | 2022-11-28 | 2023-02-23 |
| Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease Tinlarebant, Placebo - Stargardt Disease 1 | Phase 3 | Completed | Belite Bio, Inc | 104 | 2022-03-28 | 2026-07-23 |
| This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease tinlarebant - Stargardt Disease | Phase 1 / Phase 2 | Completed | RBP4 Pty Ltd | 13 | 2021-03-12 | 2024-04-12 |
| Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults BPN-14967, Placebo - Healthy Volunteers | Phase 1 | Completed | Belite Bio, Inc | 40 | 2019-07-19 | 2021-06-18 |
| Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses LBS-008, Placebos - Healthy Volunteer | Phase 1 | Completed | RBP4 Pty Ltd | 71 | 2018-11-15 | 2020-01-07 |
Stargardt Disease (3) · Geographic Atrophy (1)
Australia (5) · United States (4) · Taiwan (3) · United Kingdom (3) · China (2) · France (2) · Switzerland (2) · Belgium (1) · Czechia (1) · Germany (1) · Hong Kong (1) · Japan (1) · Netherlands (1)
Konstantin Petrukhin, PhD (1) · Sam Francis (1)